SMAD9 and neuroblastoma: Interestingly, our previous and current investigations revealed that low-stage or non-HR-NB tumors exhibit increased expression of SMAD9, despite extensive experimentation to validate the SMAD9-MYCN positive feedback loop in MYCN-amplified NB cells (Tan et al., 2022).